Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,498 | 16 | 47.3% |
| Food and Beverage | $10,729 | 433 | 44.1% |
| Honoraria | $1,375 | 1 | 5.7% |
| Travel and Lodging | $569.61 | 2 | 2.3% |
| Education | $134.03 | 17 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $7,268 | 15 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,811 | 12 | $0 (2022) |
| SK Life Science, Inc. | $2,153 | 33 | $0 (2023) |
| Amgen Inc. | $995.08 | 30 | $0 (2023) |
| ABBVIE INC. | $995.07 | 53 | $0 (2024) |
| Medtronic USA, Inc. | $917.07 | 6 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $742.14 | 28 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $582.63 | 23 | $0 (2023) |
| UCB, Inc. | $580.33 | 28 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $416.02 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $655.91 | 37 | ABBVIE INC. ($217.23) |
| 2023 | $1,496 | 73 | AbbVie Inc. ($307.09) |
| 2022 | $6,669 | 87 | Biohaven Pharmaceutical Holding Company Ltd. ($4,811) |
| 2021 | $9,339 | 105 | Biohaven Pharmaceuticals, Inc. ($7,268) |
| 2020 | $2,528 | 55 | SK Life Science, Inc. ($1,443) |
| 2019 | $1,049 | 41 | UCB, Inc. ($158.91) |
| 2018 | $950.63 | 33 | Amgen Inc. ($248.88) |
| 2017 | $1,618 | 38 | Medtronic USA, Inc. ($906.27) |
All Payment Transactions
469 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: PAIN | ||||||
| 12/05/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: EPILEPSY | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: PAIN | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Central Nervous System | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: PAIN | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: EPILEPSY | ||||||
| 08/29/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Neuropsychiatry | ||||||
| 08/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: PAIN | ||||||
| 08/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: AMANTADINE | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 899 | 1,210 | $376,275 | $160,968 |
| 2022 | 13 | 768 | 1,018 | $339,950 | $143,644 |
| 2021 | 15 | 812 | 1,046 | $364,485 | $152,292 |
| 2020 | 19 | 1,126 | 1,540 | $523,560 | $201,800 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 484 | $72,600 | $46,737 | 64.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 98 | 99 | $49,500 | $30,337 | 61.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 92 | 95 | $50,900 | $21,152 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $27,675 | $14,140 | 51.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 80 | 167 | $33,400 | $13,596 | 40.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 90 | 93 | $40,400 | $11,994 | 29.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 38 | 40 | $36,600 | $7,721 | 21.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 43 | 43 | $36,100 | $5,782 | 16.0% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2023 | 15 | 21 | $14,700 | $2,881 | 19.6% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 15 | 15 | $4,500 | $2,565 | 57.0% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 21 | 22 | $5,500 | $2,279 | 41.4% |
| 95922 | Testing of autonomic (sympathetic) nervous system function, heart rate response to breathing exercises, and passive tilt | Office | 2023 | 21 | 22 | $4,400 | $1,785 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 260 | 428 | $64,200 | $42,043 | 65.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 92 | 95 | $47,500 | $30,489 | 64.2% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 75 | 76 | $38,000 | $17,710 | 46.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 59 | 135 | $27,000 | $11,516 | 42.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 74 | 75 | $30,000 | $11,140 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $14,400 | $8,494 | 59.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 35 | 36 | $46,800 | $5,461 | 11.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $12,800 | $5,003 | 39.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 14 | 14 | $22,400 | $3,443 | 15.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 17 | 17 | $25,500 | $3,363 | 13.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 19 | 19 | $4,750 | $2,037 | 42.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $3,600 | $1,660 | 46.1% |
| 95922 | Testing of autonomic (sympathetic) nervous system function, heart rate response to breathing exercises, and passive tilt | Office | 2022 | 15 | 15 | $3,000 | $1,284 | 42.8% |
About Joseph Centofanti
Joseph Centofanti is a Specialist healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154360543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Centofanti has received a total of $24,306 in payments from pharmaceutical and medical device companies, with $655.91 received in 2024. These payments were reported across 469 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,498).
As a Medicare-enrolled provider, Centofanti has provided services to 3,605 Medicare beneficiaries, totaling 4,814 services with total Medicare billing of $658,703. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Cranston, RI
- Active Since 06/04/2006
- Last Updated 03/20/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1154360543
Products in Payments
- NURTEC ODT (Drug) $12,214
- Cenobamate (Drug) $1,375
- ACTIVA (Device) $917.07
- Aimovig (Biological) $883.79
- UBRELVY (Drug) $672.50
- NUPLAZID (Drug) $582.63
- QULIPTA (Drug) $412.10
- RYTARY (Drug) $392.40
- Briviact (Drug) $354.30
- Fycompa (Drug) $350.89
- VYEPTI (Biological) $305.16
- GOCOVRI (Drug) $291.43
- INBRIJA (Drug) $283.52
- VALTOCO (Drug) $240.08
- INGREZZA (Drug) $211.66
- NOURIANZ (Drug) $208.11
- COPAXONE (Drug) $195.56
- AUSTEDO (Drug) $195.21
- EMGALITY (Drug) $193.84
- Xadago (Drug) $155.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Cranston
Dr. Patrick Brannon, M.d, M.D
Specialist — Payments: $93.98
Dr. Lili Zeng, Da, DA
Specialist
Karen Miguel, Otr/L, OTR/L
Specialist
Mrs. Barbara Puddicombe, Otr/L, OTR/L
Specialist
Mrs. Catherine Lepage, Otr/L, Cht, OTR/L, CHT
Specialist
Mrs. Karen Mathewson, Otr/L,Cht, OTR/L,CHT
Specialist